Author

Malte Ulrich Ritter

Universitätsklinikum TübingenORCID 0000-0002-3670-7564Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

Julia SkokowaiD· 2 shared Maksim KlimiankouiD· 2 shared Andrei N. LupasiD· 1 shared Aylin Neyazi· 1 shared Ayline KübleriD· 1 shared B Krämer· 1 shared Ben Felix Broesamle· 1 shared Birte Hernandez AlvareziD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Julia SkokowaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintMar 27, 2026

Epigenetic control of S100A8/A9-driven monocytic inflammation licenses anti-leukemic functionality of immature NK cells during hematopoietic stem cell differentiation.

Ronja Larissa Schirrmann, Daniel Stowitschek, Malika Franziska Sutter…·Maya Caroline Andre

This study shows that epigenetic priming of healthy donor CD34+ stem cells drives S100A8/A9-driven inflammation, enhancing NK cell anti-leukemic activity during hematopoietic differentiation and improving response to 5-AzaC therapy in MDS.

DOI 10.64898/2026.03.25.714180

humanbulk RNA-seq

𝕏 PostBluesky

BioengineeringMolecular TherapyPeer-reviewedAug 29, 2025

Tuning of granulopoietic signaling by de novo designed agonists

Timo Ullrich, Christoph Pollmann, Malte Ulrich Ritter…·Mohammad ElGamacy

This paper designs and characterizes agonists that tune G-CSFR activity to bias granulopoiesis over proliferation, showing improved stability and selectivity compared to native G-CSF.

1 citation

humanproteomics

𝕏 PostBluesky